Bioanalytical Systems Value Stock - Dividend - Research Selection
Market price: 26,39 USD
Bioanalytical Systems Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||1.290.000|
|Free cash flow||-4.910.000|
|Liabilities & Shareholders equity||61.593.000|
|Diluted shares outstanding||10.851.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||286.357.888,00 USD|
|Raw Data Source||US GAAP in Millionen USD|
Description of the company
Bioanalytical Systems, Inc. is a contract research company providing drug discovery and development services. The Company´s clients and partners include pharmaceutical, biotechnology, academic and Government organizations. It derives its revenues from sales of its research services and drug development tools. The Company has been involved in the research of drugs to treat a number of therapeutic areas. It supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. Its principal clients are scientists engaged in analytical chemistry, drug safety evaluation, clinical trials, drug metabolism studies, pharmacokinetics and basic research, including biotechnology companies and pharmaceutical companies. It operates in two business segments: contract research services and research products, both of which address the bioanalytical, preclinical, and clinical research needs of drug developers.